Evidence map›Paper›PMID 26469842›Full record

Trial reportAmerican journal of respiratory and critical care medicine2015

Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.

Adriano R Tonelli, Mostafa K Ahmed, Laith Alkukhun, Frank Cikach, Kulwant Aulak, Raed A Dweik

Abstract readClinical TrialLetter
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Disease-specific platelet signaling defects in idiopathic pulmonary arterial hypertension.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  2. Selenium and selenoproteins in prostanoid metabolism and immunity.Critical reviews in biochemistry and molecular biology · 2019
    Review
  3. Review
  4. Article
  5. Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.American journal of respiratory and critical care medicine · 2017
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Adriano R Tonelli1 Cleveland Clinic Cleveland, Ohio and.ORCID http://orcid.org/0000-0002-2321-9545
Mostafa K Ahmed1 Cleveland Clinic Cleveland, Ohio and.
Laith Alkukhun1 Cleveland Clinic Cleveland, Ohio and.
Frank Cikach1 Cleveland Clinic Cleveland, Ohio and.
Kulwant Aulak1 Cleveland Clinic Cleveland, Ohio and.
Raed A Dweik1 Cleveland Clinic Cleveland, Ohio and.
Cleveland Clinic · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
NCATS NIH HHS KL2 TR000440NCATS NIH HHS UL1 TR000439
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antihypertensive AgentsMicrocirculationCase-Control StudiesEpoprostenolFamilial Primary Pulmonary HypertensionFemaleHumansHyperthermia, InducedIontophoresisLaser-Doppler FlowmetryMaleMicrovesselsSkinVascular DiseasesAntihypertensive AgentsEpoprostenoltreprostinil

Identifiers

PMID26469842
PMCPMC4642211
OpenAlexW2167191108

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.